跳至主要内容
临床试验/EUCTR2007-000386-38-IT
EUCTR2007-000386-38-IT进行中(未招募)不适用

PRIMARY CHEMOTHERAPY WITH AN EXTENDED SCHEDULE OF TEMOZOLOMIDE (1 WWEK ON / 1 WEEK OFF) FOR LOW GRADE OLIGODENDROGLIAL TUMORS AT RELAPSE OR PROGRESSION AFTER SURGERY: PHASE II TRIAL - ND

AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO0 个研究点开始时间: 2007年5月4日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - HISTOLOGICAL DIAGNOSIS OF GRADE II OLIGODENDROGLIOMAS AND OLIGOASTROCYTOMA;
  • - RELAPSE OR PROGRESSION OF DISEASE;
  • - AGE > 18 YEARS;
  • - ENHANCING MISURABLE LESION OF AT LEAST 1 CM IN MRI
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - HISTOLOGICAL DIAGNOSIS OF GRADE IIi OLIGODENDROGLIOMAS AND OLIGOASTROCYTOMA;
  • - NO PROGRESSION DISEASE;
  • - PREVOIUS RADIOTHERAPY OR CHEMOTHERAPY

研究者

发起方
AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO

相似试验

进行中(未招募)
1 期
Sequential treatment with chemotherapy and Blinatumomab to improve the response and survival of patients affected by a form of cancer that affects the cells from which give origin to white cells (cells present in blood)
EUCTR2017-004251-23-ITFONDAZIONE GIMEMA (GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL' ADULTO) FRANCO MANDELLI ONLUS149
进行中(未招募)
1 期
Induction chemotherapy followed by standard concurrent chemoradiotherapy in cervical cancer with para-aortic lymph node involvement: A phase III, multicenter, parallel-group randomized, controlled trial - ONCOCOL-01MedDRA version: 21.1Level: LLTClassification code: 10008229Term: Cervical cancer Class: 10029104MedDRA version: 21.1Level: LLTClassification code: 10008236Term: Cervical cancer stage IV Class: 10029104MedDRA version: 21.1Level: LLTClassification code: 10008235Term: Cervical cancer stage III Class: 10029104Cervical Cancer
CTIS2024-513576-18-00Centre Hospitalier Universitaire De Toulouse310
暂停
3 期
Induction chemotherapy followed by standard concurrent chemoradiotherapy in cervical cancer with para-aortic lymph node involvement: A phase III, multicenter, parallel-group randomized, controlled trial - ONCOCOL-01Cervical Cancer
2024-513576-18-00Centre Hospitalier Universitaire De Toulouse310
招募中
2 期
Comparing Sequence of Radiation therapy and chemotherapy before surgery in Advanced Rectal cancer [SPADE STUDY]
CTRI/2022/03/041068Institutional Intramural Funds
已完成
4 期
A clinical trial to study the effectiveness of combination of two drugs compared to standard single drug treatment in practice for the clearance of filarial infection from the infected individuals
CTRI/2012/02/002467Indian Council of Medical Research160